Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic for Gram-Negative and Gram-Positive Bacterial Research

Executive Summary: Meropenem trihydrate is a carbapenem β-lactam antibiotic with proven activity against gram-negative, gram-positive, and anaerobic bacteria, making it an essential agent in resistance and infection studies (APExBIO). It exerts its effect by inhibiting bacterial cell wall synthesis through penicillin-binding protein interaction, resulting in bactericidal activity. The compound demonstrates low minimum inhibitory concentrations (MIC90) for key clinical isolates such as Escherichia coli and Klebsiella pneumoniae at physiological pH (7.5). Meropenem trihydrate is stable in water (≥20.7 mg/mL at gentle warming) and DMSO (≥49.2 mg/mL), but not ethanol. It is featured in metabolomics-driven resistance profiling and acute infection models, with validated benchmarks and clear storage/handling guidelines (Dixon et al., 2025).

Biological Rationale

Carbapenem antibiotics are vital in research addressing multidrug-resistant bacterial infections. Meropenem trihydrate is a broad-spectrum β-lactam antibiotic active against a spectrum of pathogens, including Enterobacterales, E. coli, K. pneumoniae, and Streptococcus spp. (see internal review). Its role in experimental and diagnostic models is underpinned by its ability to inhibit both gram-negative and gram-positive bacteria, especially in the context of β-lactamase-mediated resistance. This article extends previous discussions by focusing on validated metabolomic and phenotyping benchmarks, and by detailing specific workflow integration and limitations for translational research. For a mechanistic overview, see this recent review, which this article updates with new LC-MS/MS findings.

Mechanism of Action of Meropenem trihydrate

Meropenem trihydrate acts by binding to high-affinity penicillin-binding proteins (PBPs) in bacterial cells. This interaction inhibits the final transpeptidation step of peptidoglycan synthesis, thereby disrupting cell wall integrity and leading to bacterial lysis. The compound is stable against most β-lactamases, including extended-spectrum β-lactamases (ESBLs), but is susceptible to carbapenemases produced by some Enterobacterales (Dixon et al., 2025). The efficacy of Meropenem trihydrate is pH-dependent, with enhanced antibacterial activity observed at physiological pH (7.5) compared to acidic conditions (pH 5.5).

Evidence & Benchmarks

• Meropenem trihydrate demonstrates low MIC90 values (typically ≤0.12–0.5 μg/mL) against Escherichia coli and Klebsiella pneumoniae clinical isolates at pH 7.5 (Dixon et al., 2025).
• It is effective against a broad range of aerobic and anaerobic gram-negative and gram-positive pathogens, including Enterobacter spp., Citrobacter spp., Proteus mirabilis, Morganella morganii, Streptococcus pyogenes, and Streptococcus pneumoniae (APExBIO).
• Resistance in Enterobacterales is mainly driven by carbapenemase enzymes, efflux pumps, and porin mutations, with enzymatic hydrolysis being most prevalent (Dixon et al., 2025).
• LC-MS/MS metabolomics can distinguish carbapenemase-producing from non-carbapenemase-producing Enterobacterales in under 7 hours, supporting Meropenem trihydrate's use in phenotypic resistance profiling (Dixon et al., 2025).
• In vivo studies in acute necrotizing pancreatitis rat models demonstrate Meropenem trihydrate reduces hemorrhage, fat necrosis, and pancreatic infection, with further efficacy when combined with deferoxamine (APExBIO).

For a detailed analysis of Meropenem trihydrate’s reproducibility and workflow parameters, see this authoritative guide, which this article clarifies by directly mapping quantitative benchmarks to source data.

Applications, Limits & Misconceptions

Meropenem trihydrate is used in the following research domains:

• Antibacterial agent for gram-negative and gram-positive bacterial infection models.
• Resistance mechanism studies, especially in Enterobacterales and ESBL-producing strains.
• Metabolomics-guided phenotyping of antimicrobial resistance.
• Acute infection and necrotizing pancreatitis animal models.
• Short-term cytotoxicity and antimicrobial susceptibility testing.

Common Pitfalls or Misconceptions

• Not for diagnostic or clinical use: Meropenem trihydrate from APExBIO is for research use only and not validated for patient treatment.
• Ineffective against carbapenemase-producing Enterobacterales: Carbapenemase enzymes can hydrolyze Meropenem, rendering it less effective or ineffective in these strains (Dixon et al., 2025).
• Solubility limitations: The compound is insoluble in ethanol; use water or DMSO for preparation as per validated protocols.
• pH-dependent activity: Lower efficacy is observed at acidic pH (5.5); use physiological pH buffers for accurate results.
• Short-term solution stability: Prepared solutions are suitable for short-term use only and should be stored at -20°C for optimal activity (APExBIO).

Workflow Integration & Parameters

Meropenem trihydrate (SKU B1217) is supplied as a solid form by APExBIO. It is soluble in water (≥20.7 mg/mL with gentle warming) and DMSO (≥49.2 mg/mL), but insoluble in ethanol. For stability, store at -20°C. Use freshly prepared solutions for short-term experiments. MIC testing should be performed at pH 7.5. For resistance studies, pair with LC-MS/MS metabolomics to phenotype Enterobacterales isolates within 7 hours (Dixon et al., 2025).

This article expands on previous mechanistic insights by detailing the integration of Meropenem trihydrate into modern metabolomics workflows, linking compound handling parameters to real-world resistance phenotyping.

Conclusion & Outlook

Meropenem trihydrate remains a cornerstone in antibacterial agent research, especially for studies targeting both gram-negative and gram-positive bacteria. Its validated molecular mechanism, low MIC90 values, and compatibility with modern metabolomics make it an indispensable tool for resistance and infection modeling. As resistance mechanisms evolve, Meropenem trihydrate continues to facilitate biomarker discovery and workflow standardization. For product details and purchase, visit the APExBIO Meropenem trihydrate page.